Oranda Therapeutics is a rare disease company, focused on acquiring, developing and commercialising innovative medicines to help improve the lives of patients in areas of high unmet need. We have a portfolio of late-stage rare disease assets and are building our organisation to support our first European launch in late 2025.
For Investors:
We are seeking investment to build a scalable, best in class rare disease commercialisation platform. The Oranda team has extensive BioPharma expertise, specifically in rare disease late-stage development, product licensing, commercialisation (having led over 20 successful European rare disease medicine launches), and lean organisational build out.
For Partners:
Oranda Therapeutics is seeking to further in-license and acquire rare disease medicines in late-stage clinical development. We are flexible, transparent and committed to forging creative deals and long term collaborations. We have a deep understanding of the critical success factors that drive excellence in late stage development and commercial execution.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 18 The Power Station, The Engine Room,united Kingdom
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- rare disease, medicine commercialisation, orphan drug, medicine development, medicine in-licensing, European.
- HQ
- London
Oranda Therapeutics Questions
Oranda Therapeutics's website is http://www.orandatherapeutics.com
Oranda Therapeutics's LinkedIn profile is https://uk.linkedin.com/company/oranda-therapeutics
Oranda Therapeutics has
4 employees.
View email and phone details for 4
employees at Oranda Therapeutics.
Oranda Therapeutics's industry is
Pharmaceutical Manufacturing
Oranda Therapeutics's top competitors are
Malin Corporation Plc,
Blueberry Therapeutics Ltd,
Ex- Viropharma Linkedin Page,
Zogenix, Inc.,
Nps Pharma,
Bellicum Pharmaceuticals, Inc.,
Actelion (Now Janssen Pulmonary Hypertension),
Markmaker Consulting,
Bivictrix Therapeutics Ltd,
Zevra Therapeutics.
Oranda Therapeutics's categories are Pharmaceutical Manufacturing
Oranda Therapeutics's founding year is 2023
